This Illumina Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
Take Stock Of The Week Ahead

Get all the latest Share Market trends and news to set you up for the week ahead.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Raymond James analyst John Freeman downgraded ConocoPhillips COP from Strong Buy to Outperform and lowered the price target from $157 to $124. ConocoPhillips shares closed at $98.36 on Friday. See how other analysts view this stock.
  • Barclays analyst Luke Sergott downgraded Illumina, Inc. ILMN from Equal-Weight to Underweight and lowered the price target from $130 to $100. Illumina shares closed at $111.06 on Friday. See how other analysts view this stock.
  • Citigroup analyst David Lebowitz downgraded Pliant Therapeutics, Inc. PLRX from Buy to Neutral and lowered the price target from $44 to $4. Pliant Therapeutics shares closed at $7.79 on Friday. See how other analysts view this stock.
  • UBS analyst Jon Windham downgraded the rating for Altus Power, Inc. AMPS from Buy to Neutral and maintained the price target of $5. Altus Power shares closed at $4.87 on Friday. See how other analysts view this stock.
  • Susquehanna analyst Mehdi Hosseini downgraded NetApp, Inc. NTAP from Positive to Neutral and lowered the price target from $155 to $130. NetApp shares closed at $122.91 on Friday. See how other analysts view this stock.

Considering buying ILMN stock? Here’s what analysts think:

Read This Next:

Don't miss a beat on the share market. Get real-time updates on top stock movers and trading ideas on Benzinga India Telegram channel.

Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm